Abstract

Lung cancer is the leading cause of cancer-related death. Intriguingly, males with non-small cell lung cancer (NSCLC) have a higher mortality rate than females. Here, we investigated the role of serine metabolism as a predictive marker for sensitivity to the antifolate pemetrexed in male and female NSCLC cell lines. Using [13C6] glucose tracing in NSCLC cell lines, we found that a subset of male cells generated significantly more serine from glucose than female cells. Higher serine biosynthesis was further correlated with increased sensitivity to pemetrexed in male cells only. Concordant sex differences in metabolic gene expression were evident in NSCLC and pan-cancer transcriptome datasets, suggesting a potential mechanism with wide-reaching applicability. These data were further validated by integrating antifolate drug cytotoxicity and metabolic pathway transcriptome data from pan-cancer cell lines. Together, these findings highlight the importance of considering sex differences in cancer metabolism to improve treatment for all patients.

Original languageEnglish
Article number105339
JournaliScience
Volume25
Issue number11
DOIs
StatePublished - Nov 18 2022

Keywords

  • Cancer
  • Cell biology
  • Cellular physiology

Fingerprint

Dive into the research topics of 'De novo serine biosynthesis from glucose predicts sex-specific response to antifolates in non-small cell lung cancer cell lines'. Together they form a unique fingerprint.

Cite this